Skip to main content Skip to main navigation menu Skip to site footer

Correlation between Otic Capsule Density and Serum 25(OH)D with hearing threshold in chronic kidney disease

  • Edi Handoko ,
  • Indrasworo Dyah ,
  • Sucipto Priyo Utomo ,
  • Andica Apriannisa ,


Abstract

Background: Prevalence of hearing loss in chronic kidney disease is between 40–60%. Its pathomechanism has not been fully understood but could be related to temporal bone remodeling. The bone metabolism disorder in chronic kidney disease is also manifested in vitamin D deficiency. Purpose: This study aims to learn the correlation between otic capsule density and serum 25(OH)D with a hearing threshold in chronic kidney disease without hemodialysis. Method: An observational analytic study with a cross-sectional design involving 36 patients with stage 3 and 4 chronic kidney disease Hearing was examined with Interacoustics AA222 audiometer, otic capsule density was measured using Toshiba Aquilion 128 CT while vitamin D was assessed by ELISA using ORGENTEC 25-OH Vitamin D3/D2 Assay kit. Hearing loss was defined as a hearing threshold over 25 dB on the better hearing ear. Results: Hearing loss was found in 17 of 36 subjects (47.2%). On independent sample t-test, ears with HL(n=44) has lower otic capsule density than ears without (n=28) significantly (p< 0.05; ROI1: 1.867  ± 285 vs 2.095  ± 315 HU; ROI2: 1.864 ±  190 vs 2.051  ± 293 HU). Pearson test showed a significant negative correlation between otic capsule density and hearing threshold (p<0.05; ROI1: r=-0.427; ROI2: r=-0.402). Serum 25(OH)D was insignificantly lower in a subject with HL(n=17) than without (p>0.05; 16.45  ± 6.33 vs. 17.99 + 10.57 ng/mL) and no correlation was found to a hearing threshold in chronic kidney disease. Conclusion: Significant correlation was found between otic capsule density and hearing threshold in predialysis chronic kidney disease. There were no correlation between serum 25(OH)D and hearing threshold and therefore unsuitable as a biomarker for the aforementioned condition.

Keywords: hearing loss chronic kidney disease vitamin D temporal bone bone metabolism

References

  1. Reddy E, Prakash DS, Krishna MGR. Proportion of hearing loss in chronic renal failure: Our experience. Indian Journal of Otology. 2016; 22(1):4.
  2. Rahman R, Akhtar N, Khanam A, Alam MR. Prevalence and Patterns of Hearing Loss among Chronic Kidney Disease of Various Stages in Bangladeshi Patients. American Journal of Medical Sciences and Medicine. 2016; 4(3):53-58.
  3. Jamaldeen J, Basheer A, Sarma AC, Kandasamy R. Prevalence and patterns of hearing loss among chronic kidney disease patients undergoing haemodialysis. Australas Med J. 2015; 8(2):41-6.
  4. Seo YJ, Ko SB, Ha TH, Gong TH, Bong JP, Park D-J, et al. Association of hearing impairment with chronic kidney disease: a cross-sectional study of the Korean general population. BMC nephrology. 2015; 16(1):154.
  5. Vilayur E, Gopinath B, Harris DC, Burlutsky G, McMahon CM, Mitchell P. The association between reduced GFR and hearing loss: a cross-sectional population-based study. Am J Kidney Dis. 2010; 56(4):661-9.
  6. Peyvandi A, Roozbahany NA. Hearing loss in chronic renal failure patient undergoing hemodialysis. Indian Journal of Otolaryngology and Head & Neck Surgery. 2013; 65(3):537-540.
  7. Thodi C, Thodis E, Danielides V, Pasadakis P, Vargemezis V. Hearing in renal failure. Nephrology Dialysis Transplantation. 2006; 21(11):3023-3030.
  8. Cuna V, Battaglino G, Capelli I, Sala E, Donati G, Cianciolo G, et al. Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective. Ther Apher Dial. 2015; 19(2):111-8.
  9. Erkoç MF, Bulut S, İmamoğlu H, Gümüş C, Kayataş M. CT assessment of bone remodeling in the otic capsule in chronic renal failure: association with hearing loss. American Journal of Roentgenology. 2013; 200(2):396-399.
  10. Martin KJ, González EA. Metabolic bone disease in chronic kidney disease. Journal of the American Society of Nephrology. 2007; 18(3):875-885.
  11. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). BoneKEy Rep [Review]. 2014; 3.
  12. Dusso AS. Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney International Supplements. 2011; 1(4):136-141. Available from: PMC.
  13. Monsell EM. The mechanism of hearing loss in Paget's disease of bone. The Laryngoscope. 2004; 114(4):598-606.
  14. Yıldırım YS, Apuhan T, Düzenli S, Arslan AO. Otosclerosis and vitamin D receptor gene polymorphism. American journal of otolaryngology. 2013; 34(5):454-457.
  15. Cureoglu S, Baylan MY, Paparella MM. Cochlear Otosclerosis. Curr Opin Otolaryngol Head Neck Surg. 2010; 18(5):357-62.
  16. Upala S, Rattanawong P, Vutthikraivit W, Sanguankeo A. Significant association between osteoporosis and hearing loss: a systematic review and meta-analysis. Brazilian Journal of Otorhinolaryngology. 2016.
  17. Brookes GB. Vitamin D deficiency—a new cause of cochlear deafness. The Journal of Laryngology & Otology. 1983; 97(05):405-420.
  18. Ikeda K, Kobayashi T, Itoh Z, Kusakari J, Takasaka T. Evaluation of vitamin D metabolism in patients with bilateral sensorineural hearing loss. Am J Otol. 1989; 10(1):11-13.
  19. Ikeda K, Kusakari J, Kobayashi T, Saito Y. The effect of vitamin D deficiency on the cochlear potentials and the perilymphatic ionized calcium concentration of rats. Acta Oto-Laryngologica. 1987; 104(S435):64-72.
  20. Zou J, Minasyan A, Keisala T, Zhang Y, Wang J-H, Lou Y-R, et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiology and Neurotology. 2008; 13(4):219-230.
  21. Bell A. A resonance approach to cochlear mechanics. PloS one. 2012; 7(11):e47918.
  22. Kao S-Y, Kempfle JS, Jensen JB, Perez-Fernandez D, Lysaght AC, Edge AS, et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. Neurobiology of disease. 2013; 56:25-33.
  23. Kanzaki S, Ito M, Takada Y, Ogawa K, Matsuo K. Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone. 2006; 39(2):414-419.
  24. Shewel Y, Morad G, Bassiouny M, Ebaeid T. Immunohistochemical study of the possible role of osteoprotegerin OPG in inhibition of otic capsule remodeling. Egyptian Journal of Ear, Nose, Throat and Allied Sciences. 2015; 16(1):47-53.
  25. Vik A, Brodin EE, Mathiesen EB, Brox J, Jørgensen L, Njølstad I, et al. Serum osteoprotegerin and renal function in the general population: the Tromsø Study. Clinical Kidney Journal. 2016:sfw095.
  26. Kota S, Jammula S, Kota S, Meher L, Modi K. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density. Indian J Orthop. 2013; 47(4):402-7.
  27. Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJ. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton). 2008; 13(1):63-7.

How to Cite

Handoko, E., Dyah, I., Utomo, S. P., & Apriannisa, A. (2017). Correlation between Otic Capsule Density and Serum 25(OH)D with hearing threshold in chronic kidney disease. Bali Medical Journal, 6(2), 436–439. https://doi.org/10.15562/bmj.v6i2.560
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
4

Total
19

Share

Search Panel

Edi Handoko
Google Scholar
Pubmed
BMJ Journal

Indrasworo Dyah
Google Scholar
Pubmed
BMJ Journal

Sucipto Priyo Utomo
Google Scholar
Pubmed
BMJ Journal

Andica Apriannisa
Google Scholar
Pubmed
BMJ Journal